Home > Knowledge section

< BACK

COVID 19 Resources

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The outbreak has affected almost every country in the world and is, therefore, considered a pandemic.

Many laboratories are engaged in developing a new vaccine to help stop the spread of the virus. In an effort to provide you with reliable, current information regarding COVID-19 our field of action, the development of new vaccines, we offer here some links you might find useful.


WHO daily information on COVID-19 and current situation

WHO landscape of COVID-19 candidate vaccines

Key criteria for the ethical acceptability of COVID-19 human challenge studies (PDF)

WHO Target Product Profiles for COVID-19 Vaccines


BARDA funding awards for new candidate vaccines

BARDA calls for funding
If you have a product for COVID-19 that should be added to the BARDA Portfolio you can Submit a request today so BARDA can learn about your product.


CEPI, the Coalition for Epidemic Preparedness and Innovation, also supports projects on COVID vaccines’ development.

More information at www.cepi.net and https://cepi.net/contact/?target=investor

CEPI sponsored Meeting held in March 2020 on Enhanced Disease (YouTube video)


Other useful articles on novel COVID-19 vaccine candidates


There are many vaccine trackers. A quick search yielded these examples:


WHO list of guidelines relevant to COVID product development (PDF file)

This list provides examples of existing WHO guidance documents adopted by WHO Expert Committee on Biological Standardization, published in Technical Report Series (TRS) 1, that may provide useful guidance and information for the development, production and evaluation of candidate SARS-CoV-2 vaccines2. This list is not exhaustive but focused on evaluation of vaccines. Some guidelines may also be applicable for other COVID-19 interventions such as therapeutic products (e.g. antibodies).


The core protocol to enable the evaluation of candidate vaccines against COVID-19 is available clicking on this link.

Comments are welcome until Friday 1 May 2020, at 20:00 CET to this email: covid19@who.int

Only feedback sent to this email will be taken into consideration.

Partners: